Medicare Enrolled

Dr. Mei An Tonette Ty Arias

Rheumatology · Mesquite, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1600 REPUBLIC PKWY STE 200, Mesquite, TX 75150
9722882600
In practice since 2012 (13 years)
NPI: 1467709485 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ty Arias from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ty Arias? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ty Arias

Dr. Mei An Tonette Ty Arias is a rheumatology in Mesquite, TX, with 13 years in practice. Based on federal Medicare data, Dr. Ty Arias performed 25,666 Medicare services across 205 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ty Arias received a total of $17,238 from 43 pharmaceutical and/or device companies across 883 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ty Arias is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice▲ Top 30% volume in TX$ $17,238 industry payments

Medicare Practice Summary

Medicare Utilization ↗
25,666
Medicare services
Top 30% in TX for rheumatology
205
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,974 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)25,200$4$13
Office visit, established patient (30-39 min)165$88$270
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle108$58$189
Administration of chemotherapy into vein, 1 hour or less83$101$345
Administration of chemotherapy into vein, each additional hour58$22$110
Office visit, established patient (20-29 min)52$57$184
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$17,238
Total received (2018-2024)
Avg $2,463/year across 7 years
Top 20% in TX for rheumatology
43
Companies
883
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,238 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,796
2023
$2,422
2022
$3,027
2021
$1,827
2020
$1,036
2019
$4,093
2018
$2,036

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,056
CSL Behring
$1,858
ABBVIE INC.
$1,848
AbbVie Inc.
$1,431
Novartis Pharmaceuticals Corporation
$1,255
AbbVie, Inc.
$917
UCB, Inc.
$849
AstraZeneca Pharmaceuticals LP
$764
GlaxoSmithKline, LLC.
$729
Horizon Therapeutics plc
$610
PFIZER INC.
$593
E.R. Squibb & Sons, L.L.C.
$489
Janssen Biotech, Inc.
$448
Mallinckrodt Hospital Products Inc.
$358
Genentech USA, Inc.
$341
Lilly USA, LLC
$294
Organon LLC
$280
Aurinia Pharma U.S., Inc.
$272
Celgene Corporation
$225
Radius Health, Inc.
$208
GENZYME CORPORATION
$206
Horizon Pharma plc
$181
Boehringer Ingelheim Pharmaceuticals, Inc.
$174
Janssen Scientific Affairs, LLC
$144
Takeda Pharmaceuticals U.S.A., Inc.
$121
Organon Llc
$96
Vertical Pharmaceuticals, LLC
$83
Mallinckrodt LLC
$47
SOBI, INC
$41
BioDelivery Sciences International, Inc.
$37
ARBOR PHARMACEUTICALS, INC.
$36
Fresenius Kabi USA, LLC
$32
Mallinckrodt Enterprises LLC
$29
Sandoz Inc.
$27
Alexion Pharmaceuticals, Inc.
$24
Ironwood Pharmaceuticals, Inc
$23
Octapharma USA, Inc.
$23
Antares Pharma, Inc.
$22
Assertio Therapeutics, Inc.
$17
Medtronic, Inc.
$16
Merck Sharp & Dohme Corporation
$12
HOSPIRA, INC.
$12
MEDAC PHARMA, INC.
$12
Top 3 companies account for 33.4% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · BUNAVAIL 2.1 mg 30-count box · Bimzelx · COSENTYX · Cimzia · DUZALLO · EVENITY · Enbrel · Evekeo · FORTEO · Gralise · HADLIMA · HUMIRA · HYRIMOZ · Hizentra · Horizant · Humira · IDACIO · INTELLIS ADAPTIVESTIM · KEVZARA · KINERET · KRYSTEXXA · Kineret · LORZONE · LUPKYNIS · LYRICA · METHYLPHENIDATE 72 · NEXPLANON · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · Otrexup · PENNSAID · Prolia · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TREMFYA · Tymlos · Uloric · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $67 per 100 Medicare services performed
Looking for a rheumatology in Mesquite?
Compare rheumatologys in the Mesquite area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
92
Per 100K population
3.5
County median income
$74,149
Nearest hospital
DALLAS REGIONAL MEDICAL CENTER
2.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ty Arias is a mixed practice specialist, with above-average Medicare volume (top 30% in TX), and high industry engagement (low-engagement, top 20%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ty Arias experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Ty Arias performed 25,200 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ty Arias receive payments from pharmaceutical companies?
Yes. Dr. Ty Arias received a total of $17,238 from 43 companies across 883 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ty Arias's costs compare to other rheumatologys in Mesquite?
Dr. Ty Arias's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ty Arias) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →